In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 347 for your search:
Drug:  busulfan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 to 65
Sponsor: Other
Protocol IDs: MCC-14178, NCT00361140

2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: AML99<=65 años, NCT00390715

3.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: PETHEMA-LAM07, NCT01041040

4.

Phase: Phase IV
Type: Biomarker/Laboratory analysis
Status: Enrolling by invitation
Age: 18 to 75
Sponsor: Other
Protocol IDs: BU-AdultPK/PGx1, NCT01071486

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 4 to 70
Sponsor: Other
Protocol IDs: CDR0000066968, RP 98-15, RPCI-RP-9815, NCI-V99-1527, NCT00003816

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-018-544, DFCI-80051, DFCI-CML

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 55 and under
Sponsor:
Protocol IDs: FHCRC-458, NCI-V89-0268

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 35 and under
Sponsor: Other
Protocol IDs: MT2000-18, 9504M09637, NCT00176878

9.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

10.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: HORCSCT-0904, NCT01015183

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 17
Sponsor:
Protocol IDs: GER-GPOH-AML-BFM-93, EU-93008

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no greater than 65
Sponsor: NCI
Protocol IDs: FHCRC-772.01, NCI-H94-0370

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 to 60
Sponsor: NCI
Protocol IDs: SWOG-9328, E-S9328

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor:
Protocol IDs: MRC-LU02, EU-94017

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: Other
Protocol IDs: PCI-9404, NCI-V94-0494

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP-0060-002, NCI-V95-0712

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 74
Sponsor:
Protocol IDs: EORTC-06952, ITA-GIMEMA-AIEOP-1, NCT00002701

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 1 and under 15
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-XI, EU-95036

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: GER-CML-3, EU-95042, NCT00002771

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 65
Sponsor: Other
Protocol IDs: JHOC-9333, NCI-V96-0897

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065146, MRC-LEUK-CML-2000, ECOG-E7995, MRC-LEUK-CML-IV, MRC-LEUK-CML-IVa, EU-96029, E7995, NCT00002868

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 60
Sponsor: Other
Protocol IDs: CDR0000065526, EORTC-06962, NCT00002989
1     
New Search